Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
US5866551A · kind A · utility
17Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 1996 |
| Grant date | Feb 2, 1999 |
| Priority date | — |
| Expiry date | Jan 11, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns defective recombinant adenoviruses containing an inserted gene encoding apolipoproteins, pharmaceutical compositions comprising the adenovirus, and their use for the treatment or prevention of pathologies linked to dyslipoproteinemias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.